VS

Veena Singh

Director Director DIN 01129841
DIN 01129841 First appointment May 2004 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Veena Singh

Data last updated:

Veena Singh was a Director at Moraceae Lab Private Limited (2004–2021) and Director at Arishta Infra Private Limited (from 2012). The companies operate in Pharma.

DIN 01129841
Primary Designation Director
Industry Pharma
First Appointment 31 May 2004
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Moraceae Lab Private Limited U24233UP1998PTC023472
Director31 May 20041998Active
Arishta Infra Private Limited U45400UP2012PTC049930
Director18 Apr 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arishta Infra Private Limited
Moraceae Lab Private Limited
Premium access

Shareholding and investment profile for Veena Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veena Singh

Veena Singh was first appointed on 31 May 2004 as Director at Moraceae Lab Private Limited. The most recent appointment on record is 18 Apr 2012 at Arishta Infra Private Limited.

Veena Singh held 2 earlier board appointments: Moraceae Lab Private Limited (Director, 31 May 2004 to 03 Feb 2021); Arishta Infra Private Limited (Director, from 18 Apr 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available